We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
-15.67%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$4.98B
AUM Growth
-$1.04B
Cap. Flow
+$50.1M
Cap. Flow %
1.01%
Top 10 Hldgs %
30.66%
Holding
1,260
New
93
Increased
866
Reduced
230
Closed
68

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$40.1M
2
PG icon
Procter & Gamble
PG
+$19.2M
3
MRK icon
Merck
MRK
+$12.2M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$10.3M
5
IBM icon
IBM
IBM
+$9.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$37.9M
2
AAPL icon
Apple
AAPL
+$19.7M
3
MSFT icon
Microsoft
MSFT
+$14.9M
4
HD icon
Home Depot
HD
+$14.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.67M

Sector Composition

Rank Sector Weight
1 Technology 29.34%
2 Healthcare 13.95%
3 Consumer Discretionary 12.19%
4 Financials 10.87%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTLT
351
DELISTED
CATALENT, INC.
CTLT
$2.25M 0.05%
20,937
+5,243
+33% +$534K
FRC
352
DELISTED
First Republic Bank
FRC
$2.2M 0.04%
15,234
+3,597
+31% +$539K
PTC icon
353
PTC
PTC
$17.2B
$2.17M 0.04%
20,361
+2,759
+16% +$298K
GLW icon
354
Corning
GLW
$128B
$2.16M 0.04%
68,561
-6,195
-8% -$213K
NDAQ icon
355
Nasdaq
NDAQ
$55.5B
$2.16M 0.04%
42,465
+8,124
+24% +$430K
ABMD
356
DELISTED
Abiomed Inc
ABMD
$2.16M 0.04%
8,717
+1,200
+16% +$324K
AME icon
357
Ametek
AME
$54.6B
$2.15M 0.04%
19,561
+4,579
+31% +$557K
TTD icon
358
Trade Desk
TTD
$6.39B
$2.15M 0.04%
51,325
+1,739
+4% +$95.2K
AVTR icon
359
Avantor
AVTR
$9.83B
$2.1M 0.04%
67,369
-1,837
-3% -$57.3K
CRL icon
360
Charles River Laboratories
CRL
$13.9B
$2.09M 0.04%
9,775
+1,516
+18% +$370K
DTE icon
361
DTE Energy
DTE
$28.2B
$2.09M 0.04%
16,508
+3,955
+32% +$516K
AVY icon
362
Avery Dennison
AVY
$13.5B
$2.09M 0.04%
12,900
+2,404
+23% +$411K
HII icon
363
Huntington Ingalls Industries
HII
$11.5B
$2.09M 0.04%
9,581
-12,252
-56% -$2.59M
ALNY icon
364
Alnylam Pharmaceuticals
ALNY
$31.4B
$2.09M 0.04%
14,303
+520
+4% +$73.8K
APO icon
365
Apollo Global Management
APO
$80.1B
$2.09M 0.04%
43,028
+14,225
+49% +$774K
STT icon
366
State Street
STT
$53B
$2.08M 0.04%
33,755
+7,859
+30% +$556K
ZBRA icon
367
Zebra Technologies
ZBRA
$16.8B
$2.07M 0.04%
7,044
-2,114
-23% -$736K
EIX icon
368
Edison International
EIX
$26.9B
$2.04M 0.04%
32,225
+7,533
+31% +$511K
NBIX icon
369
Neurocrine Biosciences
NBIX
$15.7B
$2.03M 0.04%
20,865
+537
+3% +$49.6K
BF.B icon
370
Brown-Forman Class B
BF.B
$12.5B
$2.03M 0.04%
28,957
+5,869
+25% +$393K
MRO
371
DELISTED
Marathon Oil Corporation
MRO
$2.02M 0.04%
89,854
-113,925
-56% -$3.05M
NVR icon
372
NVR
NVR
$16.9B
$2M 0.04%
500
+70
+16% +$298K
AEE icon
373
Ameren
AEE
$29.4B
$2M 0.04%
22,093
+5,459
+33% +$505K
CTRA
374
DELISTED
Coterra Energy
CTRA
$1.99M 0.04%
77,319
+11,527
+18% +$350K
HZNP
375
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.98M 0.04%
24,838
+18,124
+270% +$1.72M
13 14
15
16 17

Similar funds

PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
BS
Banco Santander Madrid, Spain $16.1B AUM 35.02% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $16.1B AUM 40.83% 1-Year Est. Return
NMO
Newlands Management Operations Dallas, Texas $16.6B AUM 3.91% 1-Year Est. Return

Xponance's Q2 2022 Portfolio in Review

As of Q2 2022, Xponance held 1,260 positions worth $4.98B, down 17% from $6.01B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Xponance's Q2 2022 filing shows 93 new, 866 increased, 230 reduced and 68 closed positions. Its largest new stake was Warner Bros: 370,598 shares worth $4.97M. The largest sale was Meta Platforms (Facebook), an estimated $37.9M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Xponance's largest Q2 2022 buy was Warner Bros: 370,598 shares worth $4.97M.
  • Xponance added most to UnitedHealth in Q2 2022, an estimated $40.1M increase.
  • Xponance's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $37.9M.
  • Xponance fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $2.36M.
  • Xponance's ten largest holdings make up 31% of its $4.98B portfolio in Q2 2022.
  • Xponance opened 93 new positions and closed 68 in Q2 2022.
  • Xponance's portfolio value fell 17% quarter-over-quarter to $4.98B.

Based on Xponance's 13F filing for Q2 2022, filed 2 Aug 2022.